Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFC-Lite vs LR in First-Line CLL
NCT01283386Phase 4Terminated
- Sponsor
- Roche
- Start
- Apr 2011
- Primary completion
- Mar 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in chronic lymphocytic leukemia (CLL), sponsored by Roche. Started Apr 2011; status: terminated.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01283386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283386.